{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:23:02Z","timestamp":1794003782693,"version":"4.8.0"},"reference-count":138,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T00:00:00Z","timestamp":1364428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:p>Amphetamine was discovered over 100 years ago. Since then, it has transformed from a drug that was freely available without prescription as a panacea for a broad range of disorders into a highly restricted Controlled Drug with therapeutic applications restricted to attention deficit hyperactivity disorder (ADHD) and narcolepsy. This review describes the relationship between chemical structure and pharmacology of amphetamine and its congeners. Amphetamine\u2019s diverse pharmacological actions translate not only into therapeutic efficacy, but also into the production of adverse events and liability for recreational abuse. Accordingly, the balance of benefit\/risk is the key challenge for its clinical use. The review charts advances in pharmaceutical development from the introduction of once-daily formulations of amphetamine through to lisdexamfetamine, which is the first d-amphetamine prodrug approved for the management of ADHD in children, adolescents and adults. The unusual metabolic route for lisdexamfetamine to deliver d-amphetamine makes an important contribution to its pharmacology. How lisdexamfetamine\u2019s distinctive pharmacokinetic\/pharmacodynamic profile translates into sustained efficacy as a treatment for ADHD and its reduced potential for recreational abuse is also discussed.<\/jats:p>","DOI":"10.1177\/0269881113482532","type":"journal-article","created":{"date-parts":[[2013,3,28]],"date-time":"2013-03-28T23:29:45Z","timestamp":1364513385000},"page":"479-496","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":530,"title":["Amphetamine, past and present \u2013 a pharmacological and clinical perspective"],"prefix":"10.1177","volume":"27","author":[{"given":"David J","family":"Heal","sequence":"first","affiliation":[{"name":"RenaSci Limited, Biocity, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L","family":"Smith","sequence":"additional","affiliation":[{"name":"RenaSci Limited, Biocity, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gosden","sequence":"additional","affiliation":[{"name":"RenaSci Limited, Biocity, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Nutt","sequence":"additional","affiliation":[{"name":"Department of Neuropsychopharmacology and Molecular Imaging, Division of Neuroscience & Mental Health, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,3,28]]},"reference":[{"key":"bibr1-0269881113482532","unstructured":"Adderall XR U.S. Product Label. Available at: http:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?id=49703 (accessed August 2012)."},{"key":"bibr2-0269881113482532","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v69n0903"},{"key":"bibr3-0269881113482532","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.09m05335pur"},{"key":"bibr4-0269881113482532","volume-title":"The diagnostic and statistical manual of mental disorders, fourth edition","author":"American Psychiatric Association","year":"1994"},{"key":"bibr5-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1976.01770030012002"},{"key":"bibr6-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.130.2.165"},{"key":"bibr7-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1972.01750300078015"},{"key":"bibr8-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-1-2"},{"key":"bibr9-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2396(200005)36:2<102::AID-SYN3>3.0.CO;2-#"},{"key":"bibr10-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.22.250.205"},{"key":"bibr11-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.04.015"},{"key":"bibr12-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(07)80083-X"},{"key":"bibr13-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2006.02.008"},{"key":"bibr14-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(93)90194-8"},{"key":"bibr15-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.94.3.577"},{"key":"bibr16-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707151"},{"key":"bibr17-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(02)00346-9"},{"key":"bibr18-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0306-4522(94)00507-2"},{"key":"bibr19-0269881113482532","first-page":"243","volume-title":"Stimulant drugs and ADHD: Basic and clinical neuroscience","author":"Castellanos FX","year":"2001"},{"key":"bibr20-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1996.01830070053009"},{"key":"bibr21-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00052-0"},{"key":"bibr22-0269881113482532","unstructured":"Cheetham SC, Kulkarni RS, Rowley HL, (2007) The SH rat model of ADHD has profoundly different catecholaminergic responses to amphetamine\u2019s enantiomers compared with Sprague-Dawleys. Society for Neurosciences. Abstract 386.14. Available online at: www.sfn.org (accessed August 2012)."},{"key":"bibr23-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1966.03100210088024"},{"key":"bibr24-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.14.5274"},{"key":"bibr25-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-007-9249-4"},{"key":"bibr26-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.165746"},{"key":"bibr27-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.531009"},{"key":"bibr28-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1989.01810030011002"},{"key":"bibr29-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1002\/mrdd.10079"},{"key":"bibr30-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2006.07.035"},{"key":"bibr31-0269881113482532","doi-asserted-by":"publisher","DOI":"10.2165\/11588190-000000000-00000"},{"key":"bibr32-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009357346"},{"key":"bibr33-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.18-15-05901.1998"},{"key":"bibr34-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s00787-009-0054-3"},{"key":"bibr35-0269881113482532","first-page":"4","volume":"8","author":"Faraone SV","year":"2006","journal-title":"MedGenMed"},{"key":"bibr36-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1177\/1087054706292196"},{"key":"bibr37-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2008.00771.x"},{"key":"bibr38-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900016898"},{"key":"bibr39-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2008.07.002"},{"key":"bibr40-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2008.07.020"},{"key":"bibr41-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705396"},{"key":"bibr42-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(83)90653-2"},{"key":"bibr43-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-004-2012-6"},{"key":"bibr44-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900002418"},{"key":"bibr45-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200310000-00015"},{"key":"bibr46-0269881113482532","first-page":"206","volume":"44","author":"Griffith JD","year":"1983","journal-title":"J Clin Psychiat"},{"key":"bibr47-0269881113482532","first-page":"14","volume":"37","author":"Gross MD","year":"1976","journal-title":"Dis Nerv Sys"},{"key":"bibr48-0269881113482532","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3565(24)37090-9","volume":"283","author":"Gundlah C","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr49-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.08.008"},{"key":"bibr50-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.3984.1013"},{"key":"bibr51-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb01512.x"},{"key":"bibr52-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702067"},{"key":"bibr53-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.08.020"},{"key":"bibr54-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/7854_2011_125"},{"key":"bibr55-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.03.016"},{"key":"bibr56-0269881113482532","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3565(25)30227-2","volume":"194","author":"Heikkila RE","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr57-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb02065.x"},{"key":"bibr58-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90348-8"},{"key":"bibr59-0269881113482532","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3928\/02793695-20080401-09a","volume":"46","author":"Howland RH","year":"2008","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"bibr60-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.132.8.868"},{"key":"bibr61-0269881113482532","unstructured":"Jackson HC, Rowley HL, Hackett D, (2011) Comparison of the effects of equivalent doses of lisdexamfetamine dimesylate and d-amphetamine on extracellular concentrations of striatal dopamine, locomotor activity and plasma amphetamine concentrations in freely moving rats. Abstract number 775.23. Available at: http:\/\/www.SfN.org (accessed August 2012)."},{"key":"bibr62-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200111000-00006"},{"key":"bibr63-0269881113482532","unstructured":"Jasinski D (2005) A double-blind placebo- and active-controlled, single-dose crossover pharmacodynamic and pharmacokinetic study to evaluate the safety, tolerability and abuse liability of intravenously administered NRP104 25 mg and 50 mg in healthy adult volunteers with histories of stimulant abuse. Protocol No: NRP104.A02. Available at: http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00247572 (accessed August 2012)."},{"key":"bibr64-0269881113482532","unstructured":"Jasinski DR (2006) A double-blind, randomized, placebo and active-controlled, six-period crossover study to evaluate the likeability, safety, and abuse liability of NRP104 in healthy adult volunteers with histories of stimulant abuse. Protocol No: NRP104.A03. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00248092 (accessed August 2012)."},{"key":"bibr65-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108093841"},{"key":"bibr66-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1177\/0269881109103113"},{"key":"bibr67-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0550-9"},{"key":"bibr68-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199002000-00009"},{"key":"bibr69-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-10-67"},{"key":"bibr70-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1185\/030079908X242737"},{"key":"bibr71-0269881113482532","doi-asserted-by":"publisher","DOI":"10.2165\/0044011-200828120-00002"},{"key":"bibr72-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.15-02-01308.1995"},{"key":"bibr73-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(91)90047-F"},{"key":"bibr74-0269881113482532","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709019029"},{"key":"bibr75-0269881113482532","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2008.09.1910"},{"key":"bibr76-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2008.44.5.1215724"},{"key":"bibr77-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(90)91604-F"},{"key":"bibr78-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(76)90432-9"},{"key":"bibr79-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900027541"},{"key":"bibr80-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)02542-8"},{"key":"bibr81-0269881113482532","volume-title":"An Encyclopaedia of Chemicals and Drugs","author":"Merck Index, Ninth Edition","year":"1976"},{"key":"bibr82-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1517\/14740330903279956"},{"key":"bibr83-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/BF00436152"},{"key":"bibr84-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(80)90429-3"},{"key":"bibr85-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-02-00389.2002"},{"key":"bibr86-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.01.015"},{"key":"bibr87-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0893-133X(89)90031-6"},{"key":"bibr88-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1002\/syn.890060113"},{"key":"bibr89-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb00988.x"},{"key":"bibr90-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1037\/1064-1297.13.2.111"},{"key":"bibr91-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1542\/peds.104.6.1300"},{"key":"bibr92-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1542\/peds.86.2.226"},{"key":"bibr93-0269881113482532","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S9749"},{"key":"bibr94-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0791-2"},{"key":"bibr95-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2010.09.009"},{"key":"bibr96-0269881113482532","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2007.110593"},{"key":"bibr97-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(84)90403-5"},{"key":"bibr98-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(75)90302-7"},{"key":"bibr99-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-009-8053-4"},{"key":"bibr100-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(85)90201-1"},{"key":"bibr101-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3"},{"key":"bibr102-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1002\/1098-2396(200011)38:2<167::AID-SYN8>3.0.CO;2-W"},{"key":"bibr103-0269881113482532","unstructured":"Rowley HL, Cheetham SC, Hackett D, (2011) Lisdexamfetamine dimesylate versus\n                      d\n                      -amfetamine \u2013 Hysteresis analyses of the relationships between extracellular striatal dopamine and locomotor activity measured in freely moving-rats. Abstract number 775.11. Available at: http:\/\/www.SfN.org (accessed August 2012)."},{"key":"bibr104-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-1-9"},{"key":"bibr105-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7634(99)00058-5"},{"key":"bibr106-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2009.08.004"},{"key":"bibr107-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2005.02.002"},{"key":"bibr108-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90128-0"},{"key":"bibr109-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426628"},{"key":"bibr110-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1023\/B:NERE.0000026409.76261.f3"},{"key":"bibr111-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1288-7"},{"key":"bibr112-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2007.06.025"},{"key":"bibr113-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-199501000-00014"},{"key":"bibr114-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426687"},{"key":"bibr115-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199010000-00001"},{"key":"bibr116-0269881113482532","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0301"},{"key":"bibr117-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.11.022"},{"key":"bibr118-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01751-X"},{"key":"bibr119-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1998.71010258.x"},{"key":"bibr120-0269881113482532","first-page":"385","volume":"32","author":"Tidy HL","year":"1938","journal-title":"Proc R Soc Med"},{"key":"bibr121-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/BF00428897"},{"key":"bibr122-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.11.1909"},{"key":"bibr123-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1038\/386827a0"},{"key":"bibr124-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.19.10388"},{"key":"bibr125-0269881113482532","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0022-3565(24)35115-8","volume":"291","author":"Volkow ND","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr126-0269881113482532","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0022-3565(24)37918-2","volume":"288","author":"Volkow ND","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"bibr127-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246277"},{"key":"bibr128-0269881113482532","unstructured":"Vyvanse U.S. Product Label. Available at: http:\/\/dailymed.nlm.nih.gov\/dailymed\/search.cfm?startswith=VYVANSE&x=14&y=14 (accessed August 2012)."},{"key":"bibr129-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900024056"},{"key":"bibr130-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(87)90603-0"},{"key":"bibr131-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01412.x"},{"key":"bibr132-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1744-9081-6-34"},{"key":"bibr133-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-3-17"},{"key":"bibr134-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-4-32"},{"key":"bibr135-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1177\/1087054705281121"},{"key":"bibr136-0269881113482532","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1542\/peds.53.2.236","volume":"53","author":"Winsberg BG","year":"1974","journal-title":"Pediatrics"},{"key":"bibr137-0269881113482532","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.07.018"},{"key":"bibr138-0269881113482532","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-3565(25)29645-8","volume":"187","author":"Yokel RA","year":"1973","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881113482532","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0269881113482532","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881113482532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:07:45Z","timestamp":1777507665000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881113482532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,28]]},"references-count":138,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1177\/0269881113482532"],"URL":"https:\/\/doi.org\/10.1177\/0269881113482532","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,28]]}}}